Related Experiment Video
Updated: Feb 22, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC
Guanming Jiao1, Qi Huang2, Muren Hu2
1Regeneration and Ageing Lab, School of Life Science, Shanghai University, Shanghai 200444, China.
Abstract:
The mutated in colorectal cancer (MCC) gene is an important colorectal tumor suppressor gene, although few studies have reported the microRNA(s) that could directly target MCC in colorectal cancer. Here, we used microRNA (miRNA) target prediction algorithms, and previously reported microarray data in human colorectal cancer found that only miR-4261 was predicted by all three databases to directly target MCC. Based on specimens from our own cohort of colorectal cancer patients, we further demonstrated that miR-4261 was overexpressed in colorectal cancer. Interestingly, overexpression of miR-4261 could enhance cell proliferation and G1/S phase transition of cell cycle, and promote cell migration in HCT116 and HT29 cells, while inhibition of miR-4261 had opposite effects. Luciferase reporter assay and western blot analysis confirmed MCC as a direct target of miR-4261. MCC small interfering RNA (siRNA) could abolish the suppressive effects of miR-4261 inhibitor on cell proliferation and migration in HCT116 and HT29 cell lines. Finally, we showed that therapeutic intervention with lentivirus-based miR-4261 sponge injection could effectively reduce tumor growth and inhibit cell proliferation in colorectal cancer xenograft. Collectively, our study is the first one to unravel the functional role of miR-4261, and it provides strong evidence that inhibition of miR-4261 through targeting of MCC might exert a therapeutic effect for colorectal cancer.
Insights
MicroRNA-4261 (miR-4261) promotes colorectal cancer growth by suppressing the tumor suppressor gene mutated in colorectal cancer (MCC). Inhibiting miR-4261 offers a potential therapeutic strategy for colorectal cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The mutated in colorectal cancer (MCC) gene is a critical tumor suppressor in colorectal cancer.
- Limited research exists on microRNAs (miRNAs) directly targeting MCC in colorectal cancer.
Purpose of the Study:
- To identify microRNAs targeting MCC in colorectal cancer.
- To investigate the functional role of miR-4261 in colorectal cancer progression.
- To explore the therapeutic potential of targeting miR-4261.
Main Methods:
- Utilized miRNA target prediction algorithms and microarray data.
- Analyzed miR-4261 expression in patient specimens and cell lines (HCT116, HT29).
- Performed luciferase reporter assays, Western blot, and in vivo xenograft studies.
Main Results:
- miR-4261 was predicted by multiple databases to target MCC and was overexpressed in colorectal cancer.
- Overexpression of miR-4261 enhanced cell proliferation, cell cycle progression, and migration.
- Inhibition of miR-4261 reversed these effects; MCC was confirmed as a direct target.
- Therapeutic inhibition of miR-4261 reduced tumor growth in xenografts.
Conclusions:
- This study identifies miR-4261 as a novel oncogenic miRNA in colorectal cancer.
- miR-4261 promotes colorectal cancer progression by targeting the MCC tumor suppressor gene.
- Targeting miR-4261 presents a promising therapeutic avenue for colorectal cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation

